P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.075
https://www.valueinhealthjournal.com/article/S1098-3015(22)02277-X/fulltext
Title :
P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02277-X&doi=10.1016/j.jval.2022.09.075
First page :
Section Title :
Open access? :
No
Section Order :
10261